Accelerant vs CorVel
ARX and CRVL side by side, both in insurance agents, brokers, and service. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ARX and CRVL compare
Accelerant and CorVel are about the same size, with market caps of $4.3B and $4.4B.
Accelerant grew revenue faster over the last twelve months (54.6% versus 7.1% for CorVel).
CorVel scores higher on the StockData Score (11 against 1 for Accelerant), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ARX | CRVL |
|---|---|---|
| Size and price | ||
| Market cap | $4.3B | $4.4B |
| Share price | $19.86 | $87.62 |
| Change, 1 year | 46.5% | 18.1% |
| Change, 5 years | 28.5% | 42.4% |
| Beta (5Y) | 0.34 | 0.22 |
| Employees | – | 5,239 |
| StockData Score | ||
| Total score | 1 | 11 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 6 (better) |
| Health score | 0 | 1 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 38.9× |
| P/S | 3.8× (better) | 4.5× |
| P/B | 6.0× (better) | 10.8× |
| EV/EBITDA | – | 22.6× |
| P/FCF | – | 38.9× |
| PEG | – | 2.02 |
| FCF yield | – | 2.6% |
| Fair value | – | $84.32 |
| Margin of safety | – | −3.9% |
| Growth | ||
| Revenue growth (TTM) | 54.6% (better) | 7.1% |
| Revenue growth, 5Y average | – | 11.6% |
| Net income growth (TTM) | – | 14.4% |
| EPS growth (TTM) | −3267% | 16.0% (better) |
| EPS growth, 5Y average | – | 20.3% |
| Profitability | ||
| Gross margin | – | 24.8% |
| Net margin | – | 11.7% |
| FCF margin | – | 11.6% |
| Return on equity | – | 30.7% |
| Financial health | ||
| Current ratio | – | 1.94 |
| Altman Z-score | 0.21 | 13.43 (better) |
| Piotroski F-score | – | 7 |
| Dividends and buybacks | ||
| Buyback yield | – | 1.5% |
| Shareholder yield | 0.00% | 1.5% (better) |
| Ownership | ||
| Held by institutions | 29.7% | 55.1% |
| Held by insiders | 73.7% | 40.2% |
| Insider net buying, 12 months | −$21.6M (better) | −$22.0M |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 5.2% | 3.6% |
Go deeper
- ARX stock overview
- ARX income statement
- ARX valuation and score
- CRVL stock overview
- CRVL income statement
- CRVL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.